Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

The murine monoclonal antibody mAb-1H11 raised against malondialdehyde (MDA)-modified LDL, was used to detect cross-reacting material in human atheromatous tissue and in plasma. MDA-modified LDL levels in plasma were 0.19 +/- 0.02 mg/dl (mean +/- SEM) in 44 control subjects, 0.24 +/- 0.02 mg/dl in 1...

Full description

Saved in:
Bibliographic Details
Main Authors: Holvoet, P, Perez, G, Zhao, Z, Brouwers, E, Bernar, H, Collen, D
Format: Artigo
Language:Inglês
Published: 1995
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC295944/
https://ncbi.nlm.nih.gov/pubmed/7769103
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items